Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Secreted Ly-6/uPAR-related protein 1 (SLURP-1) (ARS component B) (ARS(component B)-81/S) (Anti-neoplastic urinary protein) (ANUP)

 SLUR1_HUMAN             Reviewed;         103 AA.
P55000; Q53YJ6; Q6PUA6; Q92483;
01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
15-JUL-1998, sequence version 2.
28-FEB-2018, entry version 153.
RecName: Full=Secreted Ly-6/uPAR-related protein 1;
Short=SLURP-1;
AltName: Full=ARS component B;
AltName: Full=ARS(component B)-81/S;
AltName: Full=Anti-neoplastic urinary protein;
Short=ANUP;
Flags: Precursor;
Name=SLURP1; Synonyms=ARS;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
TISSUE=Placenta;
Mastrangeli R.;
Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
[2]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Skin;
PubMed=16354194; DOI=10.1111/j.0022-202X.2005.23973.x;
Arredondo J., Chernyavsky A.I., Webber R.J., Grando S.A.;
"Biological effects of SLURP-1 on human keratinocytes.";
J. Invest. Dermatol. 125:1236-1241(2005).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[4]
PARTIAL PROTEIN SEQUENCE, AND FUNCTION.
TISSUE=Granulocyte;
PubMed=8742060; DOI=10.1006/cyto.1996.0001;
Ridge R.J., Sloane N.H.;
"Partial N-terminal amino acid sequence of the anti-neoplastic urinary
protein (ANUP) and the anti-tumour effect of the N-terminal
nonapeptide of the unique cytokine present in human granulocytes.";
Cytokine 8:1-5(1996).
[5]
PARTIAL PROTEIN SEQUENCE, AND SIGNAL SEQUENCE CLEAVAGE SITE.
PubMed=10211827; DOI=10.1110/ps.8.4.810;
Andermann K., Wattler F., Wattler S., Heine G., Meyer M.,
Forssmann W.-G., Nehls M.;
"Structural and phylogenetic characterization of human SLURP-1, the
first secreted mammalian member of the Ly-6/uPAR protein
superfamily.";
Protein Sci. 8:810-819(1999).
[6]
TISSUE SPECIFICITY, INDUCTION, AND POSSIBLE FUNCTION.
PubMed=14721776;
Mastrangeli R., Donini S., Kelton C.A., He C., Bressan A., Milazzo F.,
Ciolli V., Borrelli F., Martelli F., Biffoni M., Serlupi-Crescenzi O.,
Serani S., Micangeli E., El Tayar N., Vaccaro R., Renda T.,
Lisciani R., Rossi M., Papoian R.;
"ARS component B: structural characterization, tissue expression and
regulation of the gene and protein (SLURP-1) associated with Mal de
Meleda.";
Eur. J. Dermatol. 13:560-570(2003).
[7]
FUNCTION, AND SUBCELLULAR LOCATION.
PubMed=14506129; DOI=10.1093/hmg/ddg320;
Chimienti F., Hogg R.C., Plantard L., Lehmann C., Brakch N.,
Fischer J., Huber M., Bertrand D., Hohl D.;
"Identification of SLURP-1 as an epidermal neuromodulator explains the
clinical phenotype of Mal de Meleda.";
Hum. Mol. Genet. 12:3017-3024(2003).
[8]
TISSUE SPECIFICITY, POSSIBLE FUNCTION, VARIANT MDM HIS-71, AND
CHARACTERIZATION OF VARIANTS MDM ARG-15 AND ARG-86.
PubMed=17008884; DOI=10.1038/sj.jid.5700551;
Favre B., Plantard L., Aeschbach L., Brakch N., Christen-Zaech S.,
de Viragh P.A., Sergeant A., Huber M., Hohl D.;
"SLURP1 is a late marker of epidermal differentiation and is absent in
Mal de Meleda.";
J. Invest. Dermatol. 127:301-308(2007).
[9]
FUNCTION.
PubMed=17286989; DOI=10.1016/j.lfs.2006.12.028;
Moriwaki Y., Yoshikawa K., Fukuda H., Fujii Y.X., Misawa H.,
Kawashima K.;
"Immune system expression of SLURP-1 and SLURP-2, two endogenous
nicotinic acetylcholine receptor ligands.";
Life Sci. 80:2365-2368(2007).
[10]
INVOLVEMENT IN MDM.
PubMed=11285253; DOI=10.1093/hmg/10.8.875;
Fischer J., Bouadjar B., Heilig R., Huber M., Lefevre C., Jobard F.,
Macari F., Bakija-Konsuo A., Ait-Belkacem F., Weissenbach J.,
Lathrop M., Hohl D., Prud'homme J.-F.;
"Mutations in the gene encoding SLURP-1 in Mal de Meleda.";
Hum. Mol. Genet. 10:875-880(2001).
[11]
INDUCTION.
PubMed=20621062; DOI=10.1016/j.bbrc.2010.07.006;
Narumoto O., Horiguchi K., Horiguchi S., Moriwaki Y.,
Takano-Ohmuro H., Shoji S., Misawa H., Yamashita N., Nagase T.,
Kawashima K., Yamashita N.;
"Down-regulation of secreted lymphocyte antigen-6/urokinase-type
plasminogen activator receptor-related peptide-1 (SLURP-1), an
endogenous allosteric alpha7 nicotinic acetylcholine receptor
modulator, in murine and human asthmatic conditions.";
Biochem. Biophys. Res. Commun. 398:713-718(2010).
[12]
FUNCTION, AND INTERACTION WITH PLAU.
PubMed=25168896; DOI=10.1167/iovs.14-15107;
Swamynathan S., Swamynathan S.K.;
"SLURP-1 modulates corneal homeostasis by serving as a soluble
scavenger of urokinase-type plasminogen activator.";
Invest. Ophthalmol. Vis. Sci. 55:6251-6261(2014).
[13]
SUBCELLULAR LOCATION, AND CHARACTERIZATION OF VARIANTS MDM HIS-71;
PRO-71; ARG-77; SER-82; SER-94 AND PRO-98.
PubMed=25919322; DOI=10.1111/bjd.13868;
Adeyo O., Oberer M., Ploug M., Fong L.G., Young S.G., Beigneux A.P.;
"Heterogeneity in the properties of mutant secreted lymphocyte antigen
6/urokinase receptor-related protein 1 (SLURP1) in Mal de Meleda.";
Br. J. Dermatol. 173:1066-1069(2015).
[14]
FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CHRNA7.
PubMed=26905431; DOI=10.1371/journal.pone.0149733;
Lyukmanova E.N., Shulepko M.A., Kudryavtsev D., Bychkov M.L.,
Kulbatskii D.S., Kasheverov I.E., Astapova M.V., Feofanov A.V.,
Thomsen M.S., Mikkelsen J.D., Shenkarev Z.O., Tsetlin V.I.,
Dolgikh D.A., Kirpichnikov M.P.;
"Human secreted Ly-6/uPAR related protein-1 (SLURP-1) is a selective
allosteric antagonist of alpha7 nicotinic acetylcholine receptor.";
PLoS ONE 11:E0149733-E0149733(2016).
[15]
STRUCTURE BY NMR OF 23-103.
PubMed=23581991; DOI=10.1134/S0006297913020090;
Shulepko M.A., Lyukmanova E.N., Paramonov A.S., Lobas A.A.,
Shenkarev Z.O., Kasheverov I.E., Dolgikh D.A., Tsetlin V.I.,
Arseniev A.S., Kirpichnikov M.P.;
"Human neuromodulator SLURP-1: bacterial expression, binding to
muscle-type nicotinic acetylcholine receptor, secondary structure, and
conformational heterogeneity in solution.";
Biochemistry (Mosc.) 78:204-211(2013).
[16]
VARIANT MDM PRO-98.
PubMed=12950349; DOI=10.1046/j.1365-2230.2003.01342.x;
Yerebakan O., Hu G., Yilmaz E., Celebi J.T.;
"A novel mutation in the ARS (component B) gene encoding SLURP-1 in a
family with Mal de Meleda.";
Clin. Exp. Dermatol. 28:542-544(2003).
[17]
VARIANTS MDM ARG-15 AND ARG-86.
PubMed=12483299; DOI=10.1007/s00439-002-0838-8;
Eckl K.M., Stevens H.P., Lestringant G.G., Westenberger-Treumann M.,
Traupe H., Hinz B., Frossard P.M., Stadler R., Leigh I.M.,
Nuernberg P., Reis A., Hennies H.C.;
"Mal de Meleda (MDM) caused by mutations in the gene for SLURP-1 in
patients from Germany, Turkey, Palestine, and the United Arab
Emirates.";
Hum. Genet. 112:50-56(2003).
[18]
VARIANTS MDM ARG-77 AND TYR-99.
PubMed=14756676; DOI=10.1111/j.0009-9163.2004.00224.x;
Mokni M., Charfeddine C., Ben Mously R., Baccouche D., Kaabi B.,
Ben Osman A., Dellagi K., Abdelhak S.;
"Heterozygous manifestations in female carriers of Mal de Meleda.";
Clin. Genet. 65:244-246(2004).
[19]
VARIANTS MDM ARG-15 AND PRO-71.
PubMed=19120323; DOI=10.1111/j.1365-2133.2008.08980.x;
Nellen R.G., van Geel M., Steijlen P.M., van Steensel M.A.;
"Compound heterozygosity for ARS component B mutations in a Dutch
patient with mal de Meleda.";
Br. J. Dermatol. 160:878-880(2009).
[20]
VARIANT MDM SER-82.
PubMed=21690549; DOI=10.1001/archdermatol.2011.138;
Gruber R., Hennies H.C., Romani N., Schmuth M.;
"A novel homozygous missense mutation in SLURP1 causing Mal de Meleda
with an atypical phenotype.";
Arch. Dermatol. 147:748-750(2011).
[21]
VARIANTS MDM ARG-15 AND SER-94.
PubMed=24604124; DOI=10.2340/00015555-1840;
Zhao L., Vahlquist A., Virtanen M., Wennerstrand L., Lind L.K.,
Lundstroem A., Hellstroem Pigg M.;
"Palmoplantar keratoderma of the Gamborg-Nielsen type is caused by
mutations in the SLURP1 gene and represents a variant of Mal de
Meleda.";
Acta Derm. Venereol. 94:707-710(2014).
-!- FUNCTION: Has an antitumor activity (PubMed:8742060). Was found to
be a marker of late differentiation of the skin. Implicated in
maintaining the physiological and structural integrity of the
keratinocyte layers of the skin (PubMed:14721776,
PubMed:17008884). In vitro down-regulates keratinocyte
proliferation; the function may involve the proposed role as
modulator of nicotinic acetylcholine receptors (nAChRs) activity.
In vitro inhibits alpha-7-dependent nAChR currents in an
allosteric manner (PubMed:14506129, PubMed:26905431). In T cells
may be involved in regulation of intracellular Ca(2+) signaling
(PubMed:17286989). Seems to have a immunomodulatory function in
the cornea (By similarity). The function may implicate a possible
role as a scavenger receptor for PLAU thereby blocking PLAU-
dependent functions of PLAUR such as in cell migration and
proliferation (PubMed:25168896). {ECO:0000250|UniProtKB:Q9Z0K7,
ECO:0000269|PubMed:14506129, ECO:0000269|PubMed:17286989,
ECO:0000269|PubMed:26905431, ECO:0000269|PubMed:8742060,
ECO:0000305|PubMed:14721776, ECO:0000305|PubMed:17008884}.
-!- SUBUNIT: Homodimer. Interacts with PLAU (PubMed:25168896).
Interacts with CHRNA7 (PubMed:26905431).
-!- INTERACTION:
P36544:CHRNA7; NbExp=2; IntAct=EBI-8830896, EBI-79333;
-!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:14506129,
ECO:0000269|PubMed:25919322, ECO:0000269|PubMed:26905431}.
-!- TISSUE SPECIFICITY: Granulocytes. Expressed in skin. Predominantly
expressed in the granular layer of skin, notably the
acrosyringium. Identified in several biological fluids such as
sweat, saliva, tears, plasma and urine.
{ECO:0000269|PubMed:14721776, ECO:0000269|PubMed:17008884}.
-!- INDUCTION: Regulated by retinoic acid, EGF and IFNG/IFN-gamma
(PubMed:14721776). Down-regulated by IL-13 in cultured human
bronchial epithelial cells (related to asthmatic condition)
(PubMed:20621062). {ECO:0000269|PubMed:14721776,
ECO:0000269|PubMed:20621062}.
-!- DISEASE: Mal de Meleda (MDM) [MIM:248300]: A rare autosomal
recessive skin disorder, characterized by diffuse transgressive
palmoplantar keratoderma with keratotic lesions extending onto the
dorsa of the hands and the feet (transgrediens). Patients may have
hyperhidrosis. Other features include perioral erythema, lichenoid
plaques on the knees and the elbows, and nail abnormalities.
{ECO:0000269|PubMed:11285253, ECO:0000269|PubMed:12483299,
ECO:0000269|PubMed:12950349, ECO:0000269|PubMed:14756676,
ECO:0000269|PubMed:17008884, ECO:0000269|PubMed:19120323,
ECO:0000269|PubMed:21690549, ECO:0000269|PubMed:24604124,
ECO:0000269|PubMed:25919322}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- CAUTION: It is not certain that ARS and ANUP are identical
proteins. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; X99977; CAA68237.1; -; Genomic_DNA.
EMBL; AY579079; AAT01436.1; -; mRNA.
EMBL; AY579080; AAT01437.1; -; mRNA.
EMBL; BC069292; AAH69292.1; -; mRNA.
EMBL; BC105133; AAI05134.1; -; mRNA.
EMBL; BC105135; AAI05136.1; -; mRNA.
CCDS; CCDS6387.1; -.
PIR; A59031; A59031.
RefSeq; NP_065160.1; NM_020427.2.
UniGene; Hs.103505; -.
UniGene; Hs.676358; -.
PDB; 2MUO; NMR; -; A=23-103.
PDB; 2MUP; NMR; -; A=23-103.
PDBsum; 2MUO; -.
PDBsum; 2MUP; -.
ProteinModelPortal; P55000; -.
SMR; P55000; -.
IntAct; P55000; 3.
STRING; 9606.ENSP00000246515; -.
iPTMnet; P55000; -.
PhosphoSitePlus; P55000; -.
BioMuta; SLURP1; -.
DMDM; 3287957; -.
PaxDb; P55000; -.
PeptideAtlas; P55000; -.
PRIDE; P55000; -.
Ensembl; ENST00000246515; ENSP00000246515; ENSG00000126233.
GeneID; 57152; -.
KEGG; hsa:57152; -.
UCSC; uc003ywy.3; human.
CTD; 57152; -.
DisGeNET; 57152; -.
EuPathDB; HostDB:ENSG00000126233.1; -.
GeneCards; SLURP1; -.
HGNC; HGNC:18746; SLURP1.
HPA; HPA050967; -.
MalaCards; SLURP1; -.
MIM; 248300; phenotype.
MIM; 606119; gene.
neXtProt; NX_P55000; -.
OpenTargets; ENSG00000126233; -.
Orphanet; 87503; Mal de Meleda.
PharmGKB; PA134936818; -.
eggNOG; ENOG410J33S; Eukaryota.
eggNOG; ENOG411196K; LUCA.
GeneTree; ENSGT00510000047304; -.
HOGENOM; HOG000035114; -.
HOVERGEN; HBG094857; -.
InParanoid; P55000; -.
OMA; PMVTRSC; -.
OrthoDB; EOG091G0UOB; -.
PhylomeDB; P55000; -.
TreeFam; TF336080; -.
GeneWiki; SLURP1; -.
GenomeRNAi; 57152; -.
PRO; PR:P55000; -.
Proteomes; UP000005640; Chromosome 8.
Bgee; ENSG00000126233; -.
CleanEx; HS_SLURP1; -.
Genevisible; P55000; HS.
GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
GO; GO:0030549; F:acetylcholine receptor activator activity; IDA:UniProtKB.
GO; GO:0005125; F:cytokine activity; NAS:UniProtKB.
GO; GO:0001775; P:cell activation; IBA:GO_Central.
GO; GO:0007155; P:cell adhesion; TAS:UniProtKB.
GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
GO; GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB.
GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
GO; GO:0010839; P:negative regulation of keratinocyte proliferation; IEA:Ensembl.
GO; GO:0050884; P:neuromuscular process controlling posture; IEA:Ensembl.
GO; GO:0038195; P:urokinase plasminogen activator signaling pathway; IDA:UniProtKB.
InterPro; IPR016054; LY6_UPA_recep-like.
InterPro; IPR027103; SLURP1.
PANTHER; PTHR10036:SF10; PTHR10036:SF10; 1.
Pfam; PF00021; UPAR_LY6; 1.
1: Evidence at protein level;
3D-structure; Complete proteome; Cytokine; Direct protein sequencing;
Disease mutation; Disulfide bond; Palmoplantar keratoderma;
Reference proteome; Secreted; Signal.
SIGNAL 1 22 {ECO:0000269|PubMed:10211827}.
CHAIN 23 103 Secreted Ly-6/uPAR-related protein 1.
/FTId=PRO_0000036167.
DOMAIN 24 73 UPAR/Ly6.
DISULFID 25 50 {ECO:0000250|UniProtKB:P0DP57,
ECO:0000250|UniProtKB:P0DP58,
ECO:0000255,
ECO:0000305|PubMed:23581991}.
DISULFID 28 37 {ECO:0000250|UniProtKB:P0DP57,
ECO:0000250|UniProtKB:P0DP58,
ECO:0000255,
ECO:0000305|PubMed:23581991}.
DISULFID 43 73 {ECO:0000250|UniProtKB:P0DP57,
ECO:0000250|UniProtKB:P0DP58,
ECO:0000255,
ECO:0000305|PubMed:23581991}.
DISULFID 77 93 {ECO:0000250|UniProtKB:P0DP57,
ECO:0000250|UniProtKB:P0DP58,
ECO:0000255,
ECO:0000305|PubMed:23581991}.
DISULFID 94 99 {ECO:0000250|UniProtKB:P0DP57,
ECO:0000250|UniProtKB:P0DP58,
ECO:0000255,
ECO:0000305|PubMed:23581991}.
VARIANT 15 15 W -> R (in MDM; no expression of the
protein; dbSNP:rs121908318).
{ECO:0000269|PubMed:12483299,
ECO:0000269|PubMed:17008884,
ECO:0000269|PubMed:19120323,
ECO:0000269|PubMed:24604124}.
/FTId=VAR_032871.
VARIANT 71 71 R -> H (in MDM; reduced expression of the
protein; decreased secretion).
{ECO:0000269|PubMed:17008884,
ECO:0000269|PubMed:25919322}.
/FTId=VAR_032872.
VARIANT 71 71 R -> P (in MDM; decreased secretion).
{ECO:0000269|PubMed:19120323,
ECO:0000269|PubMed:25919322}.
/FTId=VAR_077307.
VARIANT 77 77 C -> R (in MDM; decreased secretion;
dbSNP:rs121908319).
{ECO:0000269|PubMed:14756676,
ECO:0000269|PubMed:25919322}.
/FTId=VAR_032873.
VARIANT 82 82 P -> S (in MDM; unknown pathological
significance; no effect on secretion).
{ECO:0000269|PubMed:21690549,
ECO:0000269|PubMed:25919322}.
/FTId=VAR_077308.
VARIANT 86 86 G -> R (in MDM; reduced expression of the
protein; dbSNP:rs28937888).
{ECO:0000269|PubMed:12483299,
ECO:0000269|PubMed:17008884}.
/FTId=VAR_032874.
VARIANT 94 94 C -> S (in MDM; decreased secretion;
dbSNP:rs772388665).
{ECO:0000269|PubMed:24604124,
ECO:0000269|PubMed:25919322}.
/FTId=VAR_077309.
VARIANT 98 98 L -> P (in MDM; decreased secretion).
{ECO:0000269|PubMed:12950349,
ECO:0000269|PubMed:25919322}.
/FTId=VAR_077310.
VARIANT 99 99 C -> Y (in MDM; dbSNP:rs121908320).
{ECO:0000269|PubMed:14756676}.
/FTId=VAR_032875.
CONFLICT 17 17 M -> V (in Ref. 2; AAT01436).
{ECO:0000305}.
CONFLICT 22 22 A -> Q (in Ref. 4; AA sequence).
{ECO:0000305}.
CONFLICT 36 36 S -> A (in Ref. 4; AA sequence).
{ECO:0000305}.
STRAND 24 26 {ECO:0000244|PDB:2MUO}.
STRAND 29 31 {ECO:0000244|PDB:2MUO}.
STRAND 40 42 {ECO:0000244|PDB:2MUO}.
STRAND 49 54 {ECO:0000244|PDB:2MUO}.
STRAND 70 76 {ECO:0000244|PDB:2MUO}.
STRAND 85 87 {ECO:0000244|PDB:2MUO}.
STRAND 89 96 {ECO:0000244|PDB:2MUO}.
SEQUENCE 103 AA; 11186 MW; 07AAF6BCA8031282 CRC64;
MASRWAVQLL LVAAWSMGCG EALKCYTCKE PMTSASCRTI TRCKPEDTAC MTTLVTVEAE
YPFNQSPVVT RSCSSSCVAT DPDSIGAAHL IFCCFRDLCN SEL


Related products :

Catalog number Product name Quantity
EIAAB38705 Anti-neoplastic urinary protein,ANUP,ARS,ARS component B,ARS(component B)-81_S,Homo sapiens,Human,Secreted Ly-6_uPAR-related protein 1,SLURP1,SLURP-1
EIAAB38704 Ars,ARS component B,Mouse,Mus musculus,Secreted Ly-6_uPAR-related protein 1,Slurp1,SLURP-1
EIAAB38706 Mouse,Mus musculus,Secreted Ly-6_uPAR-related protein 2,Slurp2,SLURP-2
EIAAB38707 Homo sapiens,Human,Secreted Ly-6_uPAR-related protein 2,SLURP2,SLURP-2,UNQ871_PRO1889
10-288-22138F Calcitonin gene-related peptide-receptor component protein - CGRP-receptor component protein; CGRP-RCP; CGRPRCP 0.1 mg
10-288-22138F Calcitonin gene-related peptide-receptor component protein - CGRP-receptor component protein; CGRP-RCP; CGRPRCP 0.05 mg
EIAAB35834 Calcitonin gene-related peptide-receptor component protein,CGRPRCP,CGRP-RCP,CGRP-receptor component protein,Crcp,DNA-directed RNA polymerase III subunit RPC9,Rat,Rattus norvegicus,RNA polymerase III s
EIAAB35835 Calcitonin gene-related peptide-receptor component protein,CGRPRCP,CGRP-RCP,CGRP-receptor component protein,Crcp,DNA-directed RNA polymerase III subunit RPC9,Mouse,Mus musculus,RNA polymerase III subu
EIAAB35836 Calcitonin gene-related peptide-receptor component protein,CGRPRCP,CGRP-RCP,CGRP-receptor component protein,CRCP,DNA-directed RNA polymerase III subunit RPC9,Homo sapiens,HsC17,Human,RNA polymerase II
G9259 Secreted Ly-6 uPAR-related protein 1 (SLURP1), Human, ELISA Kit 96T
G9260 Secreted Ly-6 uPAR-related protein 1 (SLURP1), Mouse, ELISA Kit 96T
CSB-EL021784HU Human Secreted Ly-6 per uPAR-related protein 1(SLURP1) ELISA kit 96T
CSB-EL021784MO Mouse Secreted Ly-6 per uPAR-related protein 1(SLURP1) ELISA kit 96T
SLUR2_MOUSE ELISA Kit FOR Secreted Ly-6 per uPAR-related protein 2; organism: Mouse; gene name: Slurp2 96T
SLUR1_MOUSE ELISA Kit FOR Secreted Ly-6 per uPAR-related protein 1; organism: Mouse; gene name: Slurp1 96T
orb82646 Major urinary protein 1 His tag protein Major urinary protein 1 (Mup1), also known as Mup7, Up-1, Ltn-1, Mup-1, Mup-a, Mup10 and Lvtn-1, is a low molecular weight secreted protein produced predominant 100
EIAAB38042 Frizzled-related protein 1b,FRP1B,FRP-1b,Homo sapiens,Human,SARP3,SARP-3,Secreted apoptosis-related protein 3,Secreted frizzled-related protein 5,SFRP5,sFRP-5
EIAAB38026 FRP,FRP1,FRP-1,Homo sapiens,Human,SARP2,SARP-2,Secreted apoptosis-related protein 2,Secreted frizzled-related protein 1,SFRP1,sFRP-1
EIAAB38032 FKSG12,FRP2,FRP-2,Homo sapiens,Human,SARP1,SARP-1,Secreted apoptosis-related protein 1,Secreted frizzled-related protein 2,SFRP2,sFRP-2,UNQ361_PRO697
EIAAB38031 Mouse,Mus musculus,Protein SDF5,Sarp1,SARP-1,Sdf5,Secreted apoptosis-related protein 1,Secreted frizzled-related protein 2,Sfrp2,sFRP-2
EIAAB31094 Cdc91l1,Cell division cycle protein 91-like 1,GPI transamidase component PIG-U,Liver regeneration-related protein LRRGT00059,Phosphatidylinositol glycan anchor biosynthesis class U protein,Pigu,Protei
18-003-43293 Secreted frizzled-related protein 1 - sFRP-1; Frizzled-related protein 1; FRP-1; Secreted apoptosis-related protein 2; SARP-2 Polyclonal 0.1 mg Protein A
18-001-30017 Secreted frizzled-related protein 5 - sFRP-5; Secreted apoptosis-related protein 3; SARP-3; Frizzled-related protein 1b; FRP-1b Polyclonal 0.1 mg
EIAAB13500 EXOSC8,Exosome complex component RRP43,Exosome component 8,Homo sapiens,Human,OIP2,OIP-2,Opa-interacting protein 2,p9,Ribosomal RNA-processing protein 43,RRP43
EIAAB46510 Homo sapiens,Human,Kell complex 37 kDa component,Kx antigen,Membrane transport protein XK,XK,XKR1,XK-related protein 1,XRG1


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur